Delivery Order SPE2DR25D3017-SPE2DR26F3FU2
- Not listed
- On January 12, 2026, the Defense Logistics Agency awarded a delivery order valued at $1,217.64 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam 10GM, a topical pharmaceutical product. This non-set-aside, competitively awarded contract features firm fixed-price pricing and is scheduled for completion by January 13, 2026. The product will be delivered to Conshohocken, Pennsylvania, which serves as the vendor's corporate office location. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Proctofoam-HC 1%-1% foam (10 grams) under a firm fixed-price contract with a ceiling value of $1,799.37. The contract is non-set-aside and competitively awarded, with an ultimate completion date of January 6, 2026. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,675.25 to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Proctofoam-HC 1%-1% Foam in 10-gram units. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance to be completed by January 14, 2026, and fulfillment occurring at the awardee's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical...
- The Defense Logistics Agency awarded a $1,998.61 delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for Proctofoam-HC 1%-1% Foam in a 10-gram quantity. This is a firm fixed-price, non-set-aside contract with a completion date of January 13, 2026, and performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a single-award IDC...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,321.59 for Proctofoam-HC 1%-1% Foam in a 10-gram unit on December 18, 2025, with completion targeted for December 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under a larger contract vehicle. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 13, 2025, for PROCTOFOAM-HC 1%-1% Foam in 10-gram units, with a ceiling value of $3,688.42. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and is expected to be completed by June 16, 2025. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for Proctofoam-HC 1%-1% Foam in a 10-gram formulation, with a ceiling value of $1,110.89. This is a firm fixed-price delivery order with no set-aside designation, performed at the awardee's location in Conshohocken, Pennsylvania, with an ultimate completion date of January 13, 2026. The award represents a task order issued under AmerisourceBergen's parent company, Cencora, Inc.'s, larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,642.36 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram units. This delivery order was issued on October 28, 2025, with an ultimate completion date of October 29, 2025, and represents a firm fixed-price, non-set-aside procurement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and serves as a major...
- The Defense Logistics Agency awarded a delivery order valued at $2,448.95 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram quantity. This non-competitive, firm fixed-price delivery order was awarded on January 14, 2026, with an ultimate completion date of January 15, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,456.52 to AmerisourceBergen Drug Corp on January 17, 2026, for the supply of Proctofoam-HC 1%-1% Foam in 10-gram units. This is a firm fixed-price contract with no set-aside designation, reflecting a competitive award to the pharmaceutical distributor. The contract is set to complete by January 20, 2026, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is executed under...
- SPE2DR25D3017Indefinite Delivery Contract
- SPE2DR25D3017-SPE2DR26F3FU2Delivery Order
On January 22, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,306.26 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit. This firm fixed-price contract, which is not set-aside and was competitively awarded, is scheduled for ultimate completion by January 23, 2026, with performance occurring at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (valued at up to $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle. The IDC enables the contractor to supply an extensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 1/21/26 |